Peptides in skincare: effects, formulation, and scientific evidence

Peptides used in skin care are amino acid-based ingredients utilized in cosmetic formulations, among other things, to influence skin-related signaling processes, support hydration, or improve the appearance of fine lines and wrinkles. Some cosmetic peptides are precisely defined synthetic sequences, others are chemically modified versions of specific sequences, and still others exist as part of mixtures derived from larger proteins.

Although all of these materials may be referred to as peptides, a common name does not mean they share the same chemical properties, biological activity, skin-penetration ability, or level of scientific evidence.

There are human studies supporting specific peptide-containing formulations. However, discussions about peptides in cosmetics often combine several distinct scientific questions:

• Does the peptide exhibit biological activity in cells?
• Does it remain stable in the finished cosmetic product?
• Can it penetrate the skin barrier?
• Does a sufficient amount of intact peptide reach the biological site associated with the proposed mechanism?
• Does the finished product cause a measurable change in human skin?
• Can this change really be attributed to the peptide?

These questions are related to each other, but they are not equivalent.

A peptide can produce an interesting response when administered directly to cell culture while failing to reach those cells when applied in a conventional topical cosmetic. On the other hand, a finished product containing the peptide can improve the appearance of the skin even if the exact biological mechanism responsible for this improvement has not been demonstrated in its users.

Therefore, the most useful way to evaluate a cosmetic peptide is to determine:

molecules + formulation + research method + population + measured outcome.

Studying a single peptide cream can support conclusions regarding that specific cream and the conditions under which it was tested. It does not prove that every serum, ampoule, toner, mask, eye cream, or moisturizer containing the word „peptide” delivers the same result.

What are peptides in skin care?

Peptides are a chemical category, not a single active ingredient

Peptides consist of amino acid residues joined by peptide bonds.

However, this chemical definition covers a very broad group of molecules. Basic information on their structure, classification, and properties is discussed in greater detail in the explanatory guide. what peptides are, how they work, and how they are classified.

Cosmetic ingredients may contain:

• short, defined peptide sequence;
• chemically modified peptide;
• metal peptide complex;
• fragments derived from larger proteins;
• mixtures containing several peptide-linked components.

Among the factors that can affect the behavior of the peptide are:

• amino acid sequence;
• particle size;
• cargo;
• hydrophilicity;
• lipid affinity;
• chemical modifications;
• stability.

Therefore, the word „peptide” alone provides limited information about the actual function of a cosmetic ingredient.

A fatty acid group is attached to some cosmetic peptides. This is often reflected in ingredient names starting with „palmitoyl”.

Other peptides form complexes with metals. One of the widely discussed examples is the copper complex known as GHK-Cu.

Other cosmetic peptides can be acetylated or modified in other ways.

Structural differences matter because changing the chemical structure of a peptide can affect:

• stability;
• solubility;
• formulation interactions;
• interactions with skin lipids;
• susceptibility to degradation;
• potential biological behavior.

One of the examples with controlled human studies is palmitoyl pentapeptide, also referred to in the scientific literature as pal-KTTKS.

In a randomized, double-blind, placebo-controlled split-face study, a moisturizing cream containing this peptide was compared to a corresponding peptide-free cream. The study involved 93 Caucasian women aged 35–55 years, and the observation period lasted 12 weeks. Improvements in parameters related to facial wrinkles and fine lines were noted. [1]

Such a result provides much more information than a general statement:

„peptides work on wrinkles.

The study determines:

• specific peptide;
• formulation;
• method of comparison;
• the studied population;
• duration;
• measured results.

At the same time, this evidence has certain limits.

The participants do not represent all age groups, ethnic groups, skin types, or dermatological conditions.

Results also cannot be automatically transferred to:

• another peptide;
• different concentration;
• another formulation;
• alternative delivery system;
• every product containing palmitoyl peptides.

A mixture containing peptides is not the same as a defined peptide

Not every cosmetic ingredient described as containing peptides consists of a single, precisely defined molecule.

Hydrolyzed proteins are created, for example, by breaking down larger proteins into smaller fragments.

Depending on:

• starting protein;
• hydrolysis process;
• production conditions;
• cleaning;
• further processing

the received component may contain various peptide fragments, and potentially also other components.

In contrast, a defined synthetic peptide has a specific amino acid sequence.

Even then, the production quality and the actual content of the final material require analytical verification.

This distinction is important when interpreting evidence.

The results of studies regarding one defined peptide sequence cannot be automatically attributed to all protein hydrolysates.

Similarly, the study of a complex hydrolysate may not allow for the determination of which of its components is responsible for the observed effect.

Statement:

„contains peptides”

it therefore describes a broad compositional feature.

Does not provide complete information about:

• mechanism;
• concentration;
• penetration;
• stability;
• clinical efficacy.

Analytical chemistry can help determine what is actually in a product.

Research on the development of liquid chromatography coupled with tandem mass spectrometry methods for the determination of palmitoyl peptides in anti-wrinkle cosmetics demonstrates the importance of measuring peptide content in the finished formulation. [2]

However:

detection of a peptide in a cosmetic ≠ demonstration of skin penetration ≠ demonstration of biological activity ≠ demonstration of visible clinical benefit.

Each of these elements requires its own evidence.

Product names describe the format and positioning

Consumers encounter peptides in products designated as:

• peptide serum;
• peptide cream;
• peptide moisturizer;
• peptide ampoule;
• peptide toner;
• peptide essence;
• peptide eye cream;
• peptide mask;
• peptide balm;
• multi-peptide serum;
• peptide complex.

These names describe the product format or its marketing positioning.

They do not define a standardized:

• peptide concentrations;
• peptide type;
• depths of penetration;
• delivery efficiency;
• biological activity;
• level of scientific evidence.

For example, an ampoule is not automatically more concentrated than a serum.

A smaller package does not automatically mean a stronger formulation.

Similarly, the packaging itself does not confirm sterility or pharmaceutical quality.

Marketing terms such as:

„volume”, „plumping”, „lifting”, „firming”, „tox”, „Botox-like” or „collagen boosting”

needs to be translated into scientifically verifiable questions.

Does plumping mean a temporary improvement related to hydration?

Does it refer to an instrumentally measured change in the appearance of the skin surface?

Does the product suggest structural changes in living tissue?

These are different claims.

Similarly, „tox” can be exclusively a part of a marketing name.

If it is to suggest a specific neuromuscular mechanism, evidence confirming such a mechanism is needed.

A review of acetyl hexapeptide-8 clearly illustrates this problem. The proposed mechanisms related to neurotransmission are often discussed together with cosmetic effects, even though the peptide's ability to reach the biologically appropriate site remains uncertain. [3]

The proposed mechanism of action of the topically applied peptide does not prove that an ordinary cosmetic product reproduces the biological effects of injection treatment.

What is the difference between the categories of cosmetic peptides?

Functional categories describe the proposed roles

Cosmetic peptides are often divided into:

• signal peptides;
• carrier peptides;
• peptides involved in neurotransmission;
• enzyme-modulating peptides;
• hydrolysates containing peptides.

These categories can be helpful in organizing the proposed mechanisms.

However, they should not be treated as a standardized hierarchy of effectiveness.

They do not have to be mutually exclusive either.

Most importantly:

The category name does not indicate how strong the evidence is.

A single „signaling peptide” can only contain data from cell cultures.

Another may have ex vivo data.

Still another may be supported by controlled human studies.

These are very different levels of evidence.

These categories help to understand the terminology.

They do not prove that every molecule belonging to a given group has a clinically proven cosmetic benefit.

Signal peptides: visible improvement does not confirm every mechanism

A signal peptide is typically described as a peptide capable of influencing a cellular response.

In the context of skin care, the potential impact on is often discussed:

• Fibroblasts;
• extracellular matrix components;
• collagen-related pathways;
• other biological skin processes.

The pal-KTTKS study provides controlled human data indicating an improvement in specific appearance parameters compared to the corresponding base preparation. [1]

This is significant evidence.

However, a visible improvement does not necessarily validate every proposed biological stage.

For example:

reduction of wrinkle visibility ≠ direct measurement of newly synthesized collagen.

A human study can demonstrate an effect on appearance without establishing the exact molecular pathway that caused it.

Another study evaluated tetrapeptide-68 in an oil-in-water emulsion.

The randomized, double-blind, placebo-controlled study involved 25 women aged 30–65 years and lasted 12 weeks. Measurements included three-dimensional evaluation of the skin surface and participant questionnaires. [4]

This provides additional controlled human data for the specific peptide formulation.

However, the study was small.

Does not confirm:

• universal effect across all populations;
• actions of the entire class of signal peptides;
• equivalent efficacy of other formulations.

Mechanistic explanations can help interpret clinical results, but they should remain separate from what was actually measured.

Reducing wrinkle roughness is an appearance-related outcome.

Does not confirm automatically:

• collagen regeneration;
• structural tissue repair;
• reversal of biological aging;
• permanent skin remodeling.

Carrier peptides: copper binding does not prove deep delivery

GHK-Cu is commonly referred to as the copper peptide.

The term „carrier peptide” refers in this case to the relationship of the peptide with copper.

This does not mean that GHK-Cu is a universal transport system capable of carrying any cosmetic ingredients through the skin.

A study combining GHK-Cu with hyaluronic acid described effects related to collagen IV in experiments on fibroblasts and ex vivo skin. [5]

Such experiments can provide valuable mechanistic data.

They help investigate:

• biological pathways;
• formulation concepts;
• potential interactions;
• hypotheses for further research.

However:

cell culture ≠ intact living human skin.

Similarly:

ex vivo skin ≠ controlled human clinical study on cosmetics.

Direct exposure of cells to the component in the laboratory does not prove that the cream used by the consumer causes the same exposure after topical application.

The review dedicated to GHK-Cu contained in liposomes indicated limitations of available studies regarding skin penetration and the need to use appropriate measurement methods.[6]

Encapsulation can be a legitimate formulation strategy.

However:

„liposomal” ≠ proven delivery to the epidermis.

The specific formulation must be examined.

Peptides related to neurotransmission: the proposed pathway is not the same as the equivalence with treatment

Acetyl hexapeptide-8 is often discussed in the context of mechanisms related to neurotransmitter release and mimic wrinkles.

The most important scientific question, however, does not solely concern whether a molecule can affect the appropriate pathway under experimental conditions.

The next question is:

Can the local formulation deliver sufficient intact peptide to the appropriate biological site?

The review regarding acetyl hexapeptide-8 discusses limitations of penetration through the skin and uncertainties regarding the ability of the peptide to reach neuromuscular junctions. It also indicates that the mechanisms of its local action have not been fully elucidated. [3]

Therefore, terms such as:

„Botox-like”

should not be interpreted as evidence that the cosmetic product used topically:

• it reaches the same biological place;
• it works through the same mechanism;
• it produces an effect of the same strength;
• It is clinically equivalent to the botulinum toxin administered by injection.

Local products can potentially improve the appearance of fine lines through several mechanisms without showing equivalent neuromuscular effects.

The apparent cosmetic improvement and the equivalence of the mechanism are separate claims.

Absorption through the skin and formulation

Getting to the surface of the skin is not the same as getting to living tissue

The skin is not a uniform layer.

Its outermost barrier, the stratum corneum, is primarily formed by non-living corneocytes arranged in an environment rich in lipids.

Below are the living layers of the epidermis.

The true skin is even deeper.

This distinction is crucial when assessing the penetration of peptides.

Peptide detected:

on the surface of the skin

or

in samples of the lateral layer

It does not have to reach:

living layers of the epidermis

I

genuine leather.

This is of particular importance when the proposed mechanism requires access to:

• fibroblasts;
• nerves;
• enzymes;
• receptors;
• for other purposes found in the living tissue.

Demonstrating that the cosmetic product was applied correctly does not confirm exposure to the biological target.

Penetration of the peptide can be influenced by:

• particle size;
• the shape of the molecule;
• cargo;
• hydrophilicity;
• lipophilicity;
• chemical modifications;
• stability;
• the composition of the substrate;
• condition of the skin barrier.

The review of acetyl hexapeptide-8 discusses the physicochemical properties that may limit passive permeation. [3]

These results justify caution regarding broad claims regarding penetration.

However, they do not prove that every peptide behaves in the same way.

The formulation may be helpful, but its effectiveness needs to be measured.

The creators of peptide formulations can modify the molecules or delivery systems in order to influence:

• stability;
• solubility;
• release;
• interactions with lipids;
• skin exposure.

The addition of a lipid group to a peptide, for example, can alter its interactions with the lipids of the skin or the components of the formulation.

Encrustation can affect the protection, transport or release of the component.

However:

delivery strategy ≠ demonstrated delivery.

Neither lipid modification nor encapsulation automatically indicates that a biologically active peptide that is intact does reach the epidermis at an effective concentration.

The whole formulation is important.

Important variables may include:

• solvents;
• emulsifiers;
• pH;
• water activity;
• preservatives;
• other active ingredients;
• interactions between peptides;
• packaging;
• exposure to light;
• exposure to oxygen;
• storage conditions.

A peptide studied in one emulsion does not have to behave identically when placed in another:

• cream;
• tonic;
• gel;
• serum;
• essence;
• masks.

Studies on the quantification of palmitoyl peptides in cosmetics show why the entire cosmetic matrix must be taken into account when assessing the peptide content. [2]

Claims regarding delivery should therefore specify:

what peptide + what formulation + what experimental method + what skin condition.

Data obtained using damaged skin or an active device to assist in delivery should also not be automatically transferred to a conventional passive application applied to intact skin.

The change in the skin barrier changes the conditions of exposure.

What would convincing evidence of infiltration look like?

A well-designed penetration test should distinguish between individual locations.

These could be:

• the surface of the skin;
• the corneal layer;
• living epidermis;
• proper skin;
• receptor fluid in the experimental diffusion system.

The study should also include:

• the possibility of contamination between the layers;
• recovery of the peptide during sample preparation;
• analytical sensitivity;
• analytical specificity;
• degradation of the peptide;
• whether the detected signal corresponds to the intact peptide.

In a 2013 study, a HILIC-LC-MS/MS method was developed for the determination of hexapeptides in matrices relevant for in vitro skin permeation studies. These included:

• emulsions;
• receptor fluid;
• strips used to apply the corneal layer;
• separated layers of skin. [7]

The main contribution of this study was the analytical method.

The method of labeling peptides in such experimental matrices has been demonstrated.

It has not been shown that a specific consumer cosmetic product delivers a clinically significant amount of peptide to the living skin of a human being.

Distinguishing between detection and biologically relevant exposure is particularly important.

Modern analytical techniques can detect very small amounts of substances.

The mere fact of detecting the component does not mean that sufficient amounts have reached their target to elicit the proposed biological response.

It is also important what exactly was detected.

Fluorescent labeling can be useful in penetration studies.

However, a fluorescent signal associated with the marker does not automatically indicate the presence of the original, intact peptide if:

• the marker has separated;
• the peptide has undergone degradation;
• marked fragments are detected.

Chemical methods that allow the identity of the molecule to be confirmed can therefore provide important additional data.

Even effective ex vivo penetration remains a model result.

Isolated tissue does not reproduce all aspects:

• living circulation;
• metabolism;
• activity of the immune system;
• repeated application of the cosmetic product;
• barrier regeneration;
• individual differences in skin color.

A good penetration test therefore answers the question:

Where did the peptide get to?

The next question still remains:

Did such an exposure have a biological significance?

Stability is part of the delivery problem

Delivery to the skin cannot be considered independently of stability.

The peptide cannot reach its intended biological target in its original form if it has previously undergone degradation or chemical modification during:

• production;
• transportation;
• storage;
• formulation;
• the application.

In an analytical study of acetyl hexapeptide-8 in cosmetics, both the peptide itself and its oxidized form were detected, and the difficulties associated with oxidation were analyzed.[8]

This shows the importance of sample stability and preparation.

It does not prove, however, that:

• every product containing acetyl hexapeptide-8 undergoes such oxidation itself;
• oxidation necessarily leads to the formation of a harmful substance;
• all peptides have the same stability profile.

Instead, it points to a broader principle:

The name of the ingredient on the label does not fully describe its chemical state throughout the entire period of use of the product.

A more detailed discussion of what can actually be inferred from the results of purity, identity and other analytical tests can be found in the guide regarding Purity of peptides and laboratory tests.

What do cosmetic studies measure?

Different endpoints answer different questions

Cosmetic testing can measure many different parameters.

Examples include:

• moisturizing the skin;
• transcutaneous water loss;
• depth of wrinkles;
• volume of wrinkles;
• roughness of the surface;
• parameters related to flexibility;
• elasticity of the skin;
• three-dimensional topography of the skin;
• standardized photography;
• expert assessment;
• questionnaires of the participants;
• self-assessment of satisfaction.

These results are not equivalent.

Moisture refers to the water-related properties of the skin.

Transcutaneous water loss, or TEWL, measures the movement of water through the skin under certain conditions.

None of these parameters alone does not prove the synthesis of collagen.

Similarly, a three-dimensional imaging system can detect changes in the topography of the surface without determining what cellular mechanism caused them.

In a randomized pilot study, serum containing:

• niacinamide;
• postbiotic organisms;
• peptides

in 25 healthy Caucasian participants for four weeks. [9]

The study included skin hydration and other parameters, and after four weeks a difference in hydration was noted.

However, because the formulation contained several potentially active ingredients:

The result cannot be attributed solely to peptides.

This is an important distinction.

The study can provide valuable evidence regarding the finished cosmetic formulation, while providing limited information about the independent effects of a single component.

The control group decides what can be attributed to the peptide

The controlled-release study compares the active formulation with the corresponding base formulation.

This is important because the underlying material itself can affect:

• hydration;
• smoothness;
• sensations on the skin;
• reflection of light;
• the appearance of fine lines.

A moisturizing cream can improve certain skin parameters even without the tested peptide.

The split-face project can strengthen cosmetic comparison by applying different preparations on opposite sides of the same participant's face.

This reduces the portion of interpersonal variability, because each participant partially serves as their own control.

The pal-KTTKS study used a peptide-free equivalent cream and a randomized split-face design.[1]

Thanks to this, the assignment of the differences to the added peptide is more reliable than in an uncontrolled study before and after the use of the product.

However, applications remain limited to:

• the formulation under investigation;
• population;
• duration;
• measured results.

In another four-week study involving 20 healthy volunteers, face and eye area products containing:

• palmitoyl peptides;
• seed oil;
• vitamin E;
• other ingredients. [10]

Changes were noted in instrumental measurements.

The abstract does not, however, describe the corresponding control group receiving the base substance alone.

Therefore, it is not possible to reliably separate the effect of peptides from:

• the substrate;
• the other active ingredients;
• initial variability;
• other factors.

Selected studies show varying levels of evidence

The sources for the individual lines are [1], [4], [9], [5], and [11] respectively.

Comparative headlines should be interpreted in relation to the actual comparator.

The titles of scientific publications can sometimes encourage a broader interpretation than the same study allows for.

The publication regarding the cyclized hexapeptide-9 states in the title that the peptide surpasses retinol.

In the actual study, the following were compared:

• 0.002% cyclized hexapeptide-9;
• 0.002% retinol;
• the substrate

for 56 days. [11]

The concentration of retinol is important when interpreting this comparison.

The same percentage values do not automatically mean the same:

• biological forces;
• the established effective concentration;
• delivery capabilities;
• clinical significance.

One formulation of retinol does not represent all of them:

• creams with retinol;
• retinoids;
• concentrations;
• underlay;
• care regimens.

The study can therefore support conclusions regarding:

specific formulations and results that were actually compared.

It cannot automatically support the statement:

„peptides are better than retinol”.

The 56-day study also cannot demonstrate lasting superiority or long-term safety.

Experimental concentrations describe what the researchers tested.

They do not constitute general instructions for using the product.

Statistical significance and apparent importance are not the same thing

The statistically significant difference provides information about the observed data within the framework of the applied statistical model.

It does not speak automatically:

• how big was the change;
• whether users could notice it;
• whether it was clinically or cosmetically significant;
• whether it held up over time.

A useful interpretation may require taking into account:

• the magnitude of the effect;
• confidence intervals;
• the initial severity of the changes;
• variability of measurements;
• the results of the comparative group;
• duration of the study.

It is particularly easy to overestimate the percentage improvement in uncontrolled studies.

For example:

„The wrinkles improved by 30%”

Sounds impressive.

Without an appropriate control group, the change may include:

• the action of a moisturizing cream;
• natural variability;
• measurement variability;
• a change in the care routine;
• regression to the mean;
• other factors.

In a 2026 study, ex vivo experiments were combined with a clinical assessment of serum containing two peptides and other components, including glucolactone.[12]

The abstract described the groups evaluated for static and dynamic wrinkles, but no randomized comparison with the corresponding background was presented.

The observed improvement should therefore be described as a result related to the formulation under investigation.

It should not be presented as proof that only peptides were responsible for any observed change.

How should claims about products be interpreted?

Adjust the claim to the level of evidence

Different types of research answer different questions.

The biochemical experiment can show an interaction with the molecular target.

Cellular testing can show a change in a biomarker under laboratory conditions.

An ex vivo skin experiment can study tissue reaction or permeation in isolated skin.

Cosmetic testing on humans can measure visible or instrumentally assessed changes in participants.

Each provides a different kind of evidence.

For example, experiments with GHK-Cu and hyaluronic acid support the study of effects related to collagen IV in the applied models.[5]

They do not independently prove that the cream available for sale:

• provides equivalent concentrations;
• increases IV collagen in the users’ living skin;
• reduces wrinkles;
• it causes the same effect when used as a cosmetic product on its own.

Missing elements of the chain of evidence may include:

formula → stability → penetration → appropriate exposure → biological response → outcome in humans.

Similarly, the study of the finished serum should remain evidence regarding that very serum.

If the formulation also contains:

• niacinamide;
• acids;
• antioxidants;
• plant ingredients;
• humectants;
• other active substances,

the whole effect should not be automatically presented as an isolated action of the peptide mixture.

Evidence regarding the ingredient and the finished product should remain separate.

A useful hierarchy of evidence distinguishes between:

evidence regarding the peptide molecule

and

evidence regarding the finished product.

To determine whether the study of the component can be applied to a commercial product, it is necessary to compare:

• the identity of the peptide;
• chemical modification;
• concentration, if available;
• the substrate;
• delivery system;
• stability;
• period of use;
• the studied population;
• the final point.

The common name of the component is not sufficient to confirm equivalent action.

In the case of a multi-peptide serum, the number of peptides is primarily an indication of the composition.

It does not prove:

• synergy;
• more effective action;
• a broader range of biological effects;
• superiority over a preparation containing a single peptide.

Demonstrating synergy requires a research project that allows distinguishing between:

the effect of the combination

from

the effects of the individual ingredients.

In the case of claims concerning „volume” or „plumping”, it must be determined whether the measured effect results from:

• moisturizing;
• temporary smoothing of the surface;
• optical effect;
• swelling;
• structural changes in the tissue.

Temporary cosmetic improvement may still be significant.

However, it should not be described as a permanent reconstruction of tissue without appropriate evidence.

Similarly, terms such as „peptide-tox” should be treated as branding until a defined mechanism and relevant evidence are presented.

The uncertainty regarding the delivery and mechanism of acetyl hexapeptide-8 constitutes a clear reason not to treat such a language as equivalent to injectable therapy.[3]

Security requires its own evidence

Effectiveness and safety are separate questions.

The presence of a peptide in a cosmetic product does not automatically mean that every formulation containing it will be suitable for everyone.

Safety may depend on:

• the identity of the component;
• chemical form;
• concentrations;
• exposure;
• places of application;
• formulation;
• period of use;
• user characteristics.

Other components of the formulation can also influence tolerance.

These could be:

• preservatives;
• fragrance substances;
• solvents;
• plant extracts;
• acids;
• other active ingredients.

Therefore, the adverse reaction to a multi-component peptide product does not automatically mean that the peptide was the cause of it.

In a publication from 2026, a framework for the safety assessment of cosmetic peptides was proposed, including computational methods.[13]

Such tools can help organize the safety assessment and identify questions that require further investigation.

However:

The proposed safety assessment system ≠ proves that every cosmetic peptide is safe.

Similarly, the lack of adverse effects in a small study does not confirm universal tolerance.

In the study with tetrapeptide-68, no adverse reactions were observed under the conditions used. [4]

With only 25 participants, the study cannot reliably rule out:

• rare reactions;
• effects in other populations;
• effects of prolonged exposure;
• problems related to other formulations.

Cosmetic and medical claims have a different meaning

In the United States, it is whether a product is legally treated as:

• cosmetic;
• medicine;
• potentially both,

it depends, among other things, on its intended use and the claims made.

The FDA provides general information about this distinction under U.S. law regarding cosmetics.[14]

This is a matter dependent on jurisdiction.

It should not be assumed automatically that categories and regulatory requirements are identical in:

• The European Union;
• Great Britain;
• Poland;
• in other jurisdictions.

From a practical point of view, the rule is simpler:

it is necessary to accurately describe what was actually measured.

For example:

„improved the appearance of fine lines”

it is not scientifically equivalent to the statement:

„reversed the process of skin aging”.

Similarly:

„increased skin hydration”

does not mean automatically:

„he repaired the damaged tissue”.

A:

„changed the biomarkers associated with collagen in a cell culture”

does not mean automatically:

„It restored collagen in the skin of the users.”.

Evidence regarding peptides in skincare is most useful when they remain associated with:

a specific molecule + a specific formulation + a specific population + a specific measurement + a specific time.

In a broader context, it is also worth remembering that a cosmetic ingredient, a research material, pharmaceutical APIs, and a finished drug belong to different categories. The differences between them, as well as the roles of manufacturers, suppliers, and CDMO, are discussed in the article about the peptide industry, production, and market terminology.

Practical checklist for evaluating peptides in cosmetics

When evaluating the claim about a peptide cosmetic, it is worth asking a few questions.

1. What peptide is in the product?

One should look for a defined component or sequence instead of relying solely on the general word „peptides”.

2. Has the peptide been chemically modified?

Palmitoylation, acetylation, metal complexation, and other modifications can affect the properties of the peptide.

3. Was the actual finished formulation tested?

Evidence regarding an isolated component is not automatically evidence regarding every commercial product that contains it.

4. Has the peptide content been confirmed analytically?

The list of ingredients does not specify the actual quantity or chemical state of the substance throughout the entire period of use of the product.[2][8]

5. Has the penetration through the skin been measured?

If the proposed mechanism requires access to living layers of skin, the evidence should determine whether the peptide reaches the appropriate layer. [3] [6] [7]

6. What kind of study was conducted?

Cellular studies, ex vivo, uncontrolled studies in humans, controlled field studies, and randomized studies answer different questions.

7. What result was measured?

Moisture content, surface roughness, depth of wrinkles, biomarkers, and parameters related to collagen should not be considered equivalent.

8. Has appropriate control been applied?

The corresponding substrate can help distinguish the effect of the peptide from the effect of the cosmetic base itself.

9. Did the product contain many active ingredients?

If so, the improvements cannot be automatically attributed to the peptide.

10. How long did the examination take?

Short-term improvement does not automatically mean that the effect persists after discontinuation of use.

This approach helps to distinguish scientifically useful studies of peptides from broad marketing claims about the entire category.

Frequently asked questions

1. Do the peptides used topically reach the living layers of the skin?

It cannot be assumed that a peptide reaches the living layers of the skin solely because it is listed in the ingredients list. This depends on the molecule, formulation, skin barrier status, stability, and the results of appropriate measurements. Reviews regarding acetyl hexapeptide-8 and liposomal GHK-Cu indicate limitations in penetration and gaps in the available evidence. [3] [6] The detection of material on the surface or in the stratum corneum does not prove that the intact peptide has reached the living epidermis or dermis. Therefore, a strong claim regarding penetration requires measurements at individual layers and evidence that the obtained exposure is relevant to the proposed biological effect.

2. Are the peptides in cosmetics the same as the peptides administered by injection?

No. Peptides used topically in cosmetics and peptide products administered by injection should not be considered equivalent solely because both contain peptide molecules. They may significantly differ in molecule, formulation, concentration, route of exposure, target tissue, intended use, and level of evidence. The literature regarding acetyl hexapeptide-8 shows uncertainty as to whether simple topical application allows access to the biological sites invoked in the neurotransmission claims. [3] Therefore, evidence regarding an injected substance cannot be automatically transferred to serum, and cosmetic improvement does not prove equivalence to an injectable therapy.

3. Do all cosmetic peptides stimulate collagen?

No. Collagen stimulation is not a universal property of all cosmetic peptides. Different sequences have different structures and proposed functions, and some evidence comes from laboratory models rather than controlled human studies. GHK-Cu in combination with hyaluronic acid influenced IV collagen-related parameters in experiments on fibroblasts and skin ex vivo [5]. This does not prove that every copper peptide-based cosmetic or peptide ingredient produces the same effect in living human skin. Claims regarding collagen should be evaluated based on the specific peptide, formulation, experimental model, and measurement.

4. What does „palmitoyl” mean in the name of the peptide component?

„Palmitoyl” means the attachment of a palmitoyl group derived from a fatty acid, which alters the chemical properties of the component. Such modification may affect interactions with the formulation and lipids, but does not automatically imply deep penetration through the skin or clinical efficacy. The pal-KTTKS study provides controlled human data on the specific cosmetic effects of a single palmitoyl-modified peptide used in a specific moisturizing formulation.[1] These results cannot be extrapolated to any palmitoyl-modified peptide or any formulation.

5. Do copper peptides carry other cosmetic ingredients deep into the skin?

No. The term „copper peptide” does not confirm the general ability of the skin to transport other cosmetic ingredients. It describes a peptide associated with copper. Penetration and biological activity require separate evidence. A review of liposomal GHK-Cu indicated limitations in the available data regarding penetration, not universal transport properties. [6] Similarly, GHK-Cu laboratory studies do not demonstrate the transport of independent ingredients. The term „carrier peptide” should therefore be interpreted in its specific biochemical context.

6. Is a multi-peptid serum better than a product containing a single peptide?

Not necessarily. The sheer number of peptides in a formulation does not necessarily indicate greater efficacy. A multi-ingredient serum may improve measured parameters, but demonstrating that additional peptides provide an advantage requires appropriately designed comparative studies. A randomized pilot study with niacinamide, postbiotics, and peptides evaluated the combined formulation rather than the independent effects of each peptide. [9] Without appropriate comparisons of the individual components, one cannot infer either synergy or the advantage resulting from their number. Evidence regarding the finished product is more useful than the number of peptides emphasized in marketing.

7. Is the peptide ampoule stronger than a cream or serum?

Not by definition. „Ampoule,” „cream,” and „serum” describe product formats, not standardized peptide concentrations. What matters are the type of peptide, its actual content, chemical form, stability, formulation, delivery, and the effects studied. Peptide palmitoleic analysis shows why the peptide content must be evaluated in the context of the entire cosmetic matrix. [2] The size of the packaging and the product name do not determine the concentration or efficacy, and the concentration itself does not prove penetration or cosmetic benefits.

8. Does the list of ingredients allow to predict the effectiveness of the peptide product?

No. The list of ingredients helps determine what substances the manufacturer declares in the formulation, but it alone does not allow one to predict clinical or cosmetic action. Effectiveness may also depend on the chemical form, actual content, stability, formulation, skin exposure, and interactions with other ingredients. Analytical studies of acetyl hexapeptide-8 show that oxidation and sample preparation can complicate the characterization even when the known peptide name appears on the list. [8] The INCI list is therefore useful for identifying declared ingredients, but it does not replace analysis or testing of the finished product.

9. Does the improvement in hydration mean that the peptide has restored the collagen?

No. Hydration and collagen production are different outcomes. A product can increase hydration and temporarily change the appearance of fine lines without showing an increase in collagen synthesis. A four-week randomized study of a serum containing niacinamide, postbiotics, and peptides clearly demonstrates this difference, as skin parameters were evaluated in a multi-ingredient formulation.[9] An improvement in hydration can be a significant cosmetic effect, but without adequate evidence it should not be described as tissue regeneration or collagen repair.

10. Why is a substrate-controlled peptide assay useful?

A controlled-environment study helps determine whether the addition of a peptide produces an effect beyond the action of the cosmetic base itself. This is important because moisturizers and other base ingredients can independently affect hydration, smoothness, skin sensations, and the appearance of fine lines. In the pal-KTTKS study, a placebo cream without a peptide was used in a randomized split-face design, which increases the possibility of attributing differences to the added peptide. [1] However, even then the conclusions apply to a specific formulation, participants, the study time, and the measured results.

11. Are cell studies enough to prove that the peptide cream works?

No. Cell experiments can provide mechanistic data, but they cannot independently confirm the action of a finished topical product in humans. Cultured cells can be directly exposed to concentrations of the ingredient that conventional application to the skin does not replicate. The GHK-Cu study with hyaluronic acid used fibroblasts and ex vivo models, therefore the results regarding IV collagen are mechanistic evidence rather than a direct confirmation of wrinkle reduction in consumers.[5] Delivery through the skin and cosmetic effects in humans remain separate questions.

12. Has it been proven that peptides work better than retinol?

No. The cited comparison does not prove that peptides as a category are superior to retinol. In a 56-day study, cyclized hexapeptide-9 was compared with a specific formulation containing 0.002% retinol and a vehicle, and the superiority was described in selected endpoints. [11] This specific concentration and formulation of retinol does not represent all retinol products, and the same percentage values do not mean the same biological activity. The results refer to the formulations and conditions actually tested, and not to a universal advantage of peptides over retinoids.

13. Does „Botox-like” mean that the peptide serum relaxes the muscles like an injection?

No. The term „Botox-like” does not indicate equivalent penetration, biological mechanism, efficacy, or clinical effect. Acetyl hexapeptide-8 is discussed in the context of neurotransmitter release pathways, but the literature indicates uncertainty regarding the access of the topical application to the appropriate biological sites and the full mechanism of action. [3] The cosmetic product may potentially improve the appearance of mimic wrinkles without demonstrating an effect similar to injection on muscle activity. The term „Botox-like” should therefore be considered a claim requiring evidence rather than a confirmation of equivalence to botulinum toxin.

14. Are peptide products automatically suitable for sensitive skin?

No. The usefulness of a product depends on the entire formulation, exposure, and individual characteristics of the user, and not solely on the presence of the peptide. In a small study, tetrapeptide-68 was not associated with any adverse effects, but a trial involving 25 people cannot confirm universal tolerance or reliably rule out rare reactions. [4] Other ingredients such as preservatives, fragrance substances, acids, solvents, or plant extracts can also affect tolerance. Therefore, more informative data are available regarding the specific formulation and the corresponding population.

15. Does liposomal delivery prove that the peptide reaches the epidermis?

No. Liposomes are a formulation strategy or a method of delivery, not a proof of dermal exposure. A specific product must be tested to determine where the peptide goes, whether it remains intact, and what amount reaches the individual layers of the skin. A review dedicated to liposomal GHK-Cu highlighted the limitations of the available data on penetration and the need for the use of appropriate analytical methods. [6] Encapsulation can be scientifically useful but by itself does not close the evidence chain.

16. How long do the effects of peptide care last after discontinuing the product?

The studies discussed do not allow determining a general time of persistence of the effects after the end of the use of peptide cosmetics. Studies such as the 12-week pal-KTTKS trial assess results during a specific period of use and do not automatically indicate their persistence after discontinuation of the product. [1] Different effects may also behave differently. For example, the smoothing resulting from hydration may not persist as long as the hypothetical structural change of the tissue. Without an appropriate period of observation after discontinuation, no lasting benefit should be assumed.

17. Does the promising study of peptide serum prove that the peptides were responsible for the entire improvement?

No. Positive results regarding the complex serum do not prove that its peptides independently caused each observed change. The 2026 study included serum containing peptides along with other components, including gluconolactone, and presented both ex vivo and clinical results, but the abstract did not indicate a randomized comparison with a corresponding control. [12] The results may support discussion about the formulation under study, but they do not allow attributing each effect to the peptides alone. Proper controls or comparisons of the individual components are needed to reach such a conclusion.

18. Does a higher concentration of the peptide automatically mean a better product?

No. Higher concentration does not automatically mean greater effectiveness. The peptide must maintain stability, be consistent with the formulation, reach the appropriate site, and elicit the intended response. The relationship between concentration and effect may also vary between molecules. Concentrations relevant to one peptide cannot be automatically transferred to another. Analytical determination of content, such as methods developed for palmitoilic peptides in cosmetics, can determine the amount of material, but by itself does not indicate how effectively it reaches living skin or how it affects it. [2]

19. Can a peptide be effective if the proposed mechanism has not been fully confirmed?

Potentially so. A controlled study in humans may show an effect on appearance even when the exact molecular mechanism responsible for this result remains uncertain. It is important to describe the observed effect without presenting an unconfirmed mechanism as established fact. The pal-KTTKS study, for example, provides controlled human data on specific skin appearance-related effects. [1] The value of these observations does not depend on confirming each proposed molecular step, but studies should not also be used to confirm mechanisms that have not been directly measured.

20. What are the strongest evidence regarding the effects of peptides in skincare?

The strongest type of evidence depends on the specific claim. A claim of molecular activity may require biochemical or cellular studies. A claim of penetration requires appropriate analytical measurements at the individual layers of the skin. A claim of visible improvement in wrinkles is best supported by well-controlled human studies of the appropriate formulation. The most informative chain of evidence combines the identity of the peptide, the formulation, stability, delivery, biological reliability, and human results, while maintaining a distinction between each of these types of data. Studies such as the controlled pal-KTTKS trial demonstrate why comparisons of specific products in humans are more informative about cosmetic effects than broad claims about peptides as a whole category.[1]

Limitations of evidence regarding peptides in skincare

When interpreting literature on cosmetic peptides, several limitations must be taken into account.

First of all, „peptides” constitute a very broad chemical category. Evidence regarding one sequence cannot be automatically transferred to another.

Secondly, the formulation matters. The same peptide can behave differently depending on the medium, pH, stability, other ingredients, and the delivery system.

Thirdly, skin penetration remains an important evidentiary gap for some peptides. Demonstrating biological activity after direct contact with cells does not prove that simple topical application results in comparable exposure of the target organism.[3][6]

Fourthly, many cosmetic studies involve small groups. Trials involving 20–30 people can provide valuable preliminary or formulation-specific data, but they cannot confirm universal efficacy or reliably detect rare safety issues.[4][9][10]

Fifthly, multi-component formulations make it difficult to attribute effects. If a serum contains peptides along with niacinamide, acids, antioxidants, plant components, or other active substances, the improvement of the finished product cannot be automatically attributed to the peptides. [9] [12]

Sixthly, appearance-related results and mechanistic results are different things. Improving the appearance of wrinkles does not necessarily confirm collagen synthesis, and increased hydration does not prove tissue regeneration.

Seventhly, the short duration of the studies limits conclusions regarding durability. The improvement observed during several weeks of use does not indicate how long the effect will persist after discontinuation of the product.

After eight, the headlines of comparative studies require cautious interpretation. A peptide that performs better than one specific formulation and a concentration of retinol do not prove the superiority of the entire category of peptides over retinoids. [11]

Finally, the analytical detection of a peptide, its penetration, mechanism of action, and the apparent clinical effect constitute separate stages of evidence. The strongest claims regarding skin care emerge when the individual stages mutually support each other, rather than when data from one stage supplant the evidence needed in another.

Summary

Peptides are an important and scientifically diverse category of cosmetic ingredients, but „peptide skincare” is not a single standardized treatment or a single mechanism.

The individual peptide components may differ in terms of:

• sequences;
• size;
• the cargo;
• chemical modifications;
• stability;
• behavior in the formulation;
• penetration through the skin;
• the proposed mechanism;
• the level of evidence from human studies.

Controlled human studies support the appearance-related benefits of certain specific formulations containing peptides, including the pal-KTTKS cream in a randomized, double-blind, split-face trial [1]. Other peptides have smaller but controlled human studies, while some of the widely discussed mechanisms are based primarily on cell-based, ex vivo, analytical or formulation data [3][4][5][6].

The most important thing is to distinguish between:

the activity of the component,

the action of formulations,

penetration through the skin,

mechanistic evidence

and

Cosmetic results in humans.

These are interrelated questions, but the evidence regarding one does not automatically confirm the others.

The peptide can affect the biomarker in a cell culture without demonstrating effective local delivery.

It can be analytically detected in a formulation without evidence that it penetrates into the living layers of the skin.

Ready-made multi-component serums can improve the appearance of the skin without showing that the peptides were responsible for this change independently.

Similarly, marketing terms such as „multi-peptide”, „copper peptide”, „liposomal”, „plumping”, „collagen boosting” or „Botox-like” should be interpreted as descriptions of formulations or claims that require verification, rather than as evidence in themselves.

The most reliable assessment of peptides in skin care therefore requires an answer to the following questions:

Which peptide was tested?

In what formulation?

Has its stability and content been characterized?

Has penetration been demonstrated if the proposed mechanism requires it?

What kind of study was conducted?

What was actually measured?

Has appropriate control been applied?

Can the observed effect be reasonably attributed to the peptide?

Maintaining these distinctions allows us to discuss research on cosmetic peptides in detail—without rejecting promising results, but also without extending them beyond what has actually been demonstrated.

Disclaimer

The article is purely educational and scientifically informative. It discusses peptide chemistry, cosmetic formulations, penetration through the skin, analytical methods, mechanistic studies, and human cosmetic studies. It does not constitute medical or dermatological advice, diagnosis, treatment recommendations, or recommendations for the purchase or use of a specific peptide-containing product. Evidence regarding a single peptide, concentration, formulation, study population, or delivery system should not be automatically extrapolated to other products. Individuals with persistent skin problems, known allergies, significant irritation, or other dermatological issues should consult with an appropriately qualified specialist.

References

1. Robinson, L. R., Fitzgerald, N. C., Doughty, D. G., Dawes, N. C., Berge, C. A., & Bissett, D. L. (2005). Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. International Journal of Cosmetic Science, 27(3), 155–160. https://doi.org/10.1111/j.1467-2494.2005.00261.x
2. Chirita, R. I., Chaimbault, P., Archambault, J. C., Robert, I., & Elfakir, C. (2009). Development of a LC-MS/MS method to monitor palmitoyl peptides content in anti-wrinkle cosmetics. Analytica Chimica Acta, 641(1–2), 95–100. https://doi.org/10.1016/j.aca.2009.03.015
3. Zdrada-Nowak, J., Surgiel-Gemza, A., & Szatkowska, M. (2025). Acetyl hexapeptide-8 in cosmeceuticals—A review of skin permeability and efficacy. International Journal of Molecular Sciences, 26(12), Article 5722. https://doi.org/10.3390/ijms26125722
4. Lee, S. G., Kang, S. M., & Kang, H. (2024). Reduction of wrinkles using tetrapeptide-68 contained in an O/W formulation: A randomized double-blind placebo-controlled study. Pharmaceutics, 16(8), Article 987. https://doi.org/10.3390/pharmaceutics16080987
5. Jiang, F., Wu, Y., Liu, Z., Hong, M., & Huang, Y. (2023). Synergy of GHK-Cu and hyaluronic acid on collagen IV upregulation via fibroblast and ex-vivo skin tests. Journal of Cosmetic Dermatology, 22(9), 2598–2604. https://doi.org/10.1111/jocd.15763
6. Cucumber, K., Nowak, K., Wadych, E., Ruzik, L., Timerbaev, A. R., & Matczuk, M. (2025). Are we ready to measure skin permeation of modern antiaging GHK-Cu tripeptide encapsulated in liposomes? Molecules, 30(1), Article 136. https://doi.org/10.3390/molecules30010136
7. Zhou, W., Wang, P. G., Ogunsola, O. A., & Kraeling, M. E. (2013). Rapid determination of hexapeptides by hydrophilic interaction LC-MS/MS for in vitro skin-penetration studies. Bioanalysis, 5(11), 1353–1362. https://doi.org/10.4155/bio.13.60
8. Kluczyk, A., Ludwiczak, J., Modzel, M., Kuczer, M., Cebrat, M., Biernat, M., & Bąchor, R. (2021). Argireline: Needle-free Botox as analytical challenge. Chemistry & Biodiversity, 18(3), Article e2000992. https://doi.org/10.1002/cbdv.202000992
9. Rusic, D., Ivic, M., Slugan, A., Leskur, D., Modun, D., Durdov, T., Vukovic, D., Bukic, J., Bozic, J., & Seselja Perisin, A. (2024). Pilot study on the effects of a cosmetic serum containing niacinamide, postbiotics and peptides on facial skin in healthy participants: A randomized controlled trial. Life, 14(12), Article 1677. https://doi.org/10.3390/life14121677
10. Hahn, H. J., Jung, H. J., Schrammek-Drusios, M. C., Lee, S. N., Kim, J. H., Kwon, S. B., An, I. S., An, S., & Ahn, K. J. (2016). Instrumental evaluation of anti-aging effects of cosmetic formulations containing palmitoyl peptides, Silybum marianum seed oil, vitamin E and other functional ingredients on aged human skin. Experimental and Therapeutic Medicine, 12(2), 1171–1176. https://doi.org/10.3892/etm.2016.3447
11. Chang, H., Tao, K., Yang, Y., Wang, Y., Ge, M., Wang, X., Tang, S., & Yu, H. (2025). Novel cyclized hexapeptide-9 outperforms retinol against skin aging: A randomized, double-blinded, active- and vehicle-controlled clinical trial. Journal of Cosmetic Dermatology, 24(7), Article e70290. https://doi.org/10.1111/jocd.70290
12. Zhu, M., He, X., Zhu, Z., Lynch, S., Wang, H., Zhou, X., Tu, Y., Steel, A., Hsu, K. C., Niu, Y., Cho, A., Hashimoto, M., Yan, X., Su, M., & Wang, W. (2026). The effect of a serum containing acetyl hexapeptide-8, dipeptide diaminobutyroyl benzylamide diacetate and gluconolactone on skin biomarkers, wrinkles and skin texture: Ex vivo and clinical studies. International Journal of Cosmetic Science. Advance online publication. https://doi.org/10.1111/ics.70087
13. Bjerke, D. L., Li, J., Gao, Y., Hu, P., Lintner, K., & Hakozaki, T. (2026). A framework for the safety evaluation of peptides in cosmetics. Current Research in Toxicology, 10, Article 100291. https://doi.org/10.1016/j.crtox.2026.100291
14. U.S. Food and Drug Administration. (n.d.). Cosmetics & U.S. law. Retrieved September 20, 2026, from Cosmetics & U.S. law